Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants

PURPOSE: Plasma level of B-type natriuretic peptide (BNP), an emerging, sensitive, and specific biomarker of hemodynamically significant patent ductus arteriosus (PDA), rapidly decreases in infants receiving cyclooxygenase inhibitors for ductal closure. We investigated the usefulness of serial BNP m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Korean J Pediatr
Egile Nagusiak: Shin, Jeonghee, Lee, Eun Hee, Lee, Jee Hyun, Choi, Byung Min, Hong, Young Sook
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Pediatric Society 2017
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500385/
https://ncbi.nlm.nih.gov/pubmed/28690644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3345/kjp.2017.60.6.175
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak